468 related articles for article (PubMed ID: 33906820)
21. Targeting regulatory T cells in tumors.
Liu C; Workman CJ; Vignali DA
FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic targeting of regulatory T cells in cancer.
Shan F; Somasundaram A; Bruno TC; Workman CJ; Vignali DAA
Trends Cancer; 2022 Nov; 8(11):944-961. PubMed ID: 35853825
[TBL] [Abstract][Full Text] [Related]
23. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Ohue Y; Nishikawa H
Cancer Sci; 2019 Jul; 110(7):2080-2089. PubMed ID: 31102428
[TBL] [Abstract][Full Text] [Related]
24. Metabolic advantages of regulatory T cells dictated by cancer cells.
Kondo M; Kumagai S; Nishikawa H
Int Immunol; 2024 Feb; 36(2):75-86. PubMed ID: 37837615
[TBL] [Abstract][Full Text] [Related]
25. FoxP3
Saleh R; Elkord E
Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
[TBL] [Abstract][Full Text] [Related]
26. Regulatory T-cell development in the tumor microenvironment.
Itahashi K; Irie T; Nishikawa H
Eur J Immunol; 2022 Aug; 52(8):1216-1227. PubMed ID: 35879813
[TBL] [Abstract][Full Text] [Related]
27. Roles of regulatory T cells in cancer immunity.
Takeuchi Y; Nishikawa H
Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
[TBL] [Abstract][Full Text] [Related]
28. T Regulatory Cells and Priming the Suppressive Tumor Microenvironment.
Paluskievicz CM; Cao X; Abdi R; Zheng P; Liu Y; Bromberg JS
Front Immunol; 2019; 10():2453. PubMed ID: 31681327
[TBL] [Abstract][Full Text] [Related]
29. Cellular immune responses towards regulatory cells.
Larsen SK
Dan Med J; 2016 Jan; 63(1):B5188. PubMed ID: 26726907
[TBL] [Abstract][Full Text] [Related]
30. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
31. Anti-regulatory T cell vaccines in immunotherapy: focusing on FoxP3 as target.
Mousavi-Niri N; Naseroleslami M; Hadjati J
Hum Vaccin Immunother; 2019; 15(3):620-624. PubMed ID: 30633616
[TBL] [Abstract][Full Text] [Related]
32. Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review.
Kaboli PJ; Zhang L; Xiang S; Shen J; Li M; Zhao Y; Wu X; Zhao Q; Zhang H; Lin L; Yin J; Wu Y; Wan L; Yi T; Li X; Cho CH; Li J; Xiao Z; Wen Q
Curr Med Chem; 2020; 27(28):4673-4698. PubMed ID: 31584362
[TBL] [Abstract][Full Text] [Related]
33. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
34. [The Role of Regulatory T-cells in Antitumor Immune Response].
Klabusay M
Klin Onkol; 2015; 28 Suppl 4():4S23-7. PubMed ID: 26647885
[TBL] [Abstract][Full Text] [Related]
35. Targeting regulatory T cell metabolism in disease: Novel therapeutic opportunities.
Halvorson T; Tuomela K; Levings MK
Eur J Immunol; 2023 Sep; 53(9):e2250002. PubMed ID: 36891988
[TBL] [Abstract][Full Text] [Related]
36. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
38. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.
Wang H; Franco F; Tsui YC; Xie X; Trefny MP; Zappasodi R; Mohmood SR; Fernández-García J; Tsai CH; Schulze I; Picard F; Meylan E; Silverstein R; Goldberg I; Fendt SM; Wolchok JD; Merghoub T; Jandus C; Zippelius A; Ho PC
Nat Immunol; 2020 Mar; 21(3):298-308. PubMed ID: 32066953
[TBL] [Abstract][Full Text] [Related]
39. Tumors establish resistance to immunotherapy by regulating T
Marshall LA; Marubayashi S; Jorapur A; Jacobson S; Zibinsky M; Robles O; Hu DX; Jackson JJ; Pookot D; Sanchez J; Brovarney M; Wadsworth A; Chian D; Wustrow D; Kassner PD; Cutler G; Wong B; Brockstedt DG; Talay O
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243932
[TBL] [Abstract][Full Text] [Related]
40. Regulatory T cells in cancer immunotherapy.
Tanaka A; Sakaguchi S
Cell Res; 2017 Jan; 27(1):109-118. PubMed ID: 27995907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]